EMEA-001061-PIP01-10-M03
Key facts
| Invented name |
Velphoro
|
| Active substance |
Sucroferric oxyhydroxide
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/0196/2018
|
| PIP number |
EMEA-001061-PIP01-10-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of hyperphosphataemia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Vifor Fresenius Medical Care Renal Pharma France
E-mail: info@viforpharma.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001061-PIP01-10-M03
|
| Compliance opinion date |
20/09/2019
|
| Compliance outcome |
positive
|